Spanish Red Biotech Pipeline

Amgen

bemarituzumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Digestive System
Indication: Advanced and untreated gastric and gastroesophageal junction cancer with overexpression of FGFR2b
Phase: 1Phase I in Spain